9342-8530 Québec Inc. Company Review & Valuation

OTC Markets
Latest Price

About 9342-8530 Québec Inc.

9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada.

It focuses on molecular diagnostic tests for the detection and management of cancer.

The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test.

It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services.

The company was formerly known as DiagnoCure Inc.

9342-8530 Québec Inc.

was founded in 1994 and is headquartered in Quebec, Canada.

HQ Location
Quebec, Canada

Stock Price

Price data not available for 9342-8530 Québec Inc..


Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top


Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2022 Valuu Analytics Sàrl